Properties of 130 kDa subunit of monkey aldehyde oxidase

被引:3
作者
Asakawa, Tasuku [1 ]
Itoh, Kunio [1 ]
Adachi, Mayuko [1 ]
Hoshino, Kouichi [1 ]
Watanabe, Nobuaki [2 ]
Tanaka, Yorihisa [1 ]
机构
[1] Tohoku Pharmaceut Univ, Dept Drug Metab & Pharmacokinet, Aoba Ku, Sendai, Miyagi 9818558, Japan
[2] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1408710, Japan
关键词
aldehyde oxidase; subunit; Escherichia coli expression; monkey;
D O I
10.1248/bpb.31.380
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously demonstrated the existence of a minor 130 kDa subunit in the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)/Western blot analysis of monkey liver cytosol and expressed monkey aldehyde oxidase (AO) in Escherichia coli. In contrast, the 130 kDa subunit was not observed in rat AO. In the current study, the properties of the 130 kDa subunit were investigated from the viewpoint of species differences in the presence of the subunit and AO activity. Monkey AO with His-tag at the N- and C-terminus were expressed, and were immunoanalyzed with anti-AO and anti-His-tag antisera. The results revealed that the minor 130 kDa subunit was produced by cleavage at the N-terminal side of the 150 kDa subunit. The cleavage point was shown to be located between 188Leu and 189Pro of 150 kDa AO subunit by the Edman degradation method. The two amino acids related to the cleavage are contained in the linkage between the 2Fe-2S and FAD domains in AO of human and monkey, but not in AO of rat and mouse. As a fact, the 130 kDa subunit was observed in AO of human and monkey, but not in AO of rat and mouse, suggesting the two amino acids might be one reason of a species difference in the formation of the 130 kDa subunit. However, the existence of the 130 kDa subunit is not associated with the species differences in AO activity, because the cleavage results in the loss of 2Fe-2S cluster domain essential for exertion of AO activity.
引用
收藏
页码:380 / 385
页数:6
相关论文
共 31 条
[1]  
Acheampong AA, 1996, XENOBIOTICA, V26, P1035
[2]   MOLYBDENUM HYDROXYLASES AS DRUG-METABOLIZING-ENZYMES [J].
BEEDHAM, C .
DRUG METABOLISM REVIEWS, 1985, 16 (1-2) :119-156
[3]   Ziprasidone metabolism, aldehyde oxidase, and clinical implications [J].
Beedham, C ;
Miceli, JJ ;
Obach, RS .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (03) :229-232
[4]   The role of non-P450 enzymes in drug oxidation [J].
Beedham, C .
PHARMACY WORLD & SCIENCE, 1997, 19 (06) :255-263
[5]  
Beedham C, 1987, Prog Med Chem, V24, P85, DOI 10.1016/S0079-6468(08)70420-X
[6]  
Beedham C., 1998, METABOLISM XENOBIOTI, P51
[7]  
BEEDHAM C, 2002, ENZYME SYSTEMS METAB, P147
[8]  
Calzi ML, 1995, J BIOL CHEM, V270, P31037, DOI 10.1074/jbc.270.52.31037
[9]   Cloning, expression, and characterization of male cynomolgus monkey liver aldehyde oxidase [J].
Hoshino, Kouichi ;
Itoh, Kunio ;
Masubuchi, Akiko ;
Adachi, Mayuko ;
Asakawa, Tasuku ;
Watanabe, Nobuaki ;
Kosaka, Toshiyuki ;
Tanaka, Yorihisa .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (07) :1191-1198
[10]   Molecular cloning of retinal oxidase aldehyde oxidase cDNAs from rabbit and mouse livers and functional expression of recombinant mouse retinal oxidase cDNA in Escherichia coli [J].
Huang, DY ;
Furukawa, A ;
Ichikawa, Y .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 364 (02) :264-272